Draft Genome Sequence of a Clinical Isolate of Serratia marcescens, Strain AH0650_Sm1

Genome Announcements
Yu WanKathryn E Holt

Abstract

Serratia marcescens strain AH0650_Sm1 is a clinical multidrug-resistant isolate from Australia. Here, we report its annotated draft genome comprising 20 contigs. We identified chromosomal antimicrobial resistance genes including a tet(41) variant, an aac(6')-Ic variant, ampC, a metallo-beta-lactamase, and several putative multidrug efflux pumps, as well as a novel prophage.

References

Jul 1, 1992·Antimicrobial Agents and Chemotherapy·K J ShawP Downey
Aug 8, 1968·The New England Journal of Medicine·J N WilfertE H Kass
Nov 22, 1997·Journal of Medical Microbiology·A Hejazi, F R Falkiner
Oct 1, 1951·A.M.A. Archives of Internal Medicine·R P WHEATL A RANTZ
Feb 20, 2007·Applied and Environmental Microbiology·Stuart A ThompsonJ Vaun McArthur
Jun 6, 2009·Bioinformatics·Samuel AssefaMatthew Berriman
Dec 15, 2010·Bioinformatics·Marten BoetzerWalter Pirovano
Jun 16, 2011·Nucleic Acids Research·You ZhouDavid S Wishart
Oct 7, 2011·Clinical Microbiology Reviews·Steven D Mahlen
Apr 18, 2012·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Anton BankevichPavel A Pevzner
Jun 27, 2012·Genome Biology·Marten Boetzer, Walter Pirovano
Oct 23, 2013·Antimicrobial Agents and Chemotherapy·Sushim Kumar GuptaJean-Marc Rolain
Mar 20, 2014·Bioinformatics·Torsten Seemann
Apr 30, 2014·Antimicrobial Agents and Chemotherapy·Alessandra CarattoliHenrik Hasman
Nov 26, 2014·Genome Medicine·Michael InouyeKathryn E Holt

❮ Previous
Next ❯

Citations

Feb 23, 2019·International Journal of Environmental Research and Public Health·Maria Luisa CristinaAnna Maria Spagnolo

❮ Previous
Next ❯

Datasets Mentioned

BETA
LFJS00000000

Software Mentioned

SSPACE
ANNOT
GapFiller
ABACAS
SPAdes
AlignGraph
PlasmidFinder
Prokka

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

The Indian Journal of Medical Research
R A BhujwalaS Dutta
Genome Announcements
Ayslu M MardanovaMargarita R Sharipova
Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología
Francisco Silva O
Revista clínica española
J M Alés ReinleinF Cachon García
© 2021 Meta ULC. All rights reserved